NIH’s Phase I malaria trial of monoclonal antibody opens enrolment

NIAID research nurse Jennifer Cunningham looks on as a healthy volunteer receives an infusion of CIS43LS. Credit: NIAID.



  • NIH’s Phase I malaria trial of monoclonal antibody opens enrolment